The key, she continued, is how to design the coverage, which populations to prioritize and which support programs to implement to ensure adherence and better medical and financial results. Impact on insurance premiums While the clinical promise of GLP-1s is expanding, their growing demand and high cost have raised concerns about their impact on premiums
Consequently, the potential for this class of drugs is enormous and may be a paradigm shift not only for the management of obesity but also for several other conditions
Scand J Clin Lab Invest 1992
When these symptoms affect the feet they can become not only uncomfortable but also limiting for daily mobility and quality of life
Novos 2022 investor report saw an 84% growth in obesity-related sales between 2021 and 2022
These effects are central to research on appetite control, eating behavior, and caloric intake regulation, particularly in early or moderate intervention models